Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $29.1 million.

  • Icu Medical's Capital Expenditures rose 4605.73% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.5 million, marking a year-over-year increase of 263.88%. This contributed to the annual value of $79.4 million for FY2024, which is 538.78% down from last year.
  • Per Icu Medical's latest filing, its Capital Expenditures stood at $29.1 million for Q3 2025, which was up 4605.73% from $19.7 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Capital Expenditures peaked at $29.9 million during Q4 2023, and registered a low of $14.0 million during Q1 2021.
  • Its 5-year average for Capital Expenditures is $20.3 million, with a median of $19.9 million in 2024.
  • Per our database at Business Quant, Icu Medical's Capital Expenditures tumbled by 4490.83% in 2021 and then skyrocketed by 6827.77% in 2022.
  • Quarter analysis of 5 years shows Icu Medical's Capital Expenditures stood at $22.1 million in 2021, then fell by 2.18% to $21.6 million in 2022, then skyrocketed by 38.62% to $29.9 million in 2023, then decreased by 19.56% to $24.1 million in 2024, then increased by 20.76% to $29.1 million in 2025.
  • Its Capital Expenditures stands at $29.1 million for Q3 2025, versus $19.7 million for Q2 2025 and $14.6 million for Q1 2025.